A website to provide support for people who have or have had any type of cancer, for their caregivers and for their family members.
Results 1 to 4 of 4

Thread: BCC skin cancer and then MOHS

  1. #1
    Newbie New User
    Join Date
    Sep 2018
    Posts
    3

    Lightbulb BCC skin cancer and then MOHS

    Hi everyone,

    I was diagnosed with BCC and then the doctor performed MOHS. There is no scarring at all! There is a darkness and an slight indentation on my nose where he removed the cancerous layer. My question is: will the indentation "fill in" or will there always be that look and can this be corrected? I am very thankful that is looks as great as it does, despite the discoloration and indentation.

    I had a tiny bump on my nose 5 years ago and the doc said it was just a milia. Fast forward, 5 years later, it was still there. It was unattractive to me and I wanted it removed. The doc said it looked suspicious and sure enough it was Basal Cell Carcinoma. What a shocker! I never thought that's what it was. It just looked like a pimple that never went away.

    Glad to have joined this forum.

    Thanks!

  2. #2
    Newbie New User
    Join Date
    Apr 2016
    Posts
    5
    I'm 75 years old. I've had a BCC removed from my ear, a SCC removed from my arm, and a Melanoma removed from my forehead. When the doctors tell me this is going to leave a mark, I tell them at my age I'm supposed to have a few marks here and there.

  3. #3
    Super Moderator Top User po18guy's Avatar
    Join Date
    Feb 2012
    Posts
    9,858
    Sorry to welcoe you here, but welcome you are! A friend's mother had a melanoma near the inside corner of her eye. It was removed with MOHS, but she had plastic surgery to restore the area, due to its location. It would be worth at least consulting with such a surgeon, so as to hear what is likely and weigh your options.
    05/08-07/08 Tumor appears behind left ear. Followed by serial medical incompetence on the parts of PCP, veteran oncologist and pathologist (misdiagnosis via non-diagnosis). Providential guidance to proper care at an NCI designated comprehensive cancer center.
    07/08 Age 56 DX 1) Peripheral T-Cell Lymphoma-Not Otherwise Specified. Stage IV-B, >50 ("innumerable") tumors, bone marrow involvement.
    08/08-12/08 Four cycles CHOEP14 + four cycles GND (Cyclofosfamide, Doxorubicin, Vincristine, Etoposide, Prednisone & Gemcitabine, Navelbine, Doxil)
    02/09 2) Relapse.
    03/09-06/13 Clinical trial of Romidepsin > long-term study. NED for 64 twenty-eight day cycles, dose tapered.
    07/13 3) Relapse, 4) Suspected Mutation.
    08/13-02/14 Romidepsin increased, stopped for lack of response. Watch & Wait.
    09/14 Relapse/Progression. Visible cervical nodes appear within 4 days of being checked clear.
    10/06/14 One cycle Belinostat. Discontinued to enter second clinical trial.
    10/25/14 Clinical trial of Alisertib/Failed - Progression.
    01/12/15 Belinostat resumed/Failed - Progression. 02/23/15
    02/24/15 Pralatrexate/Failed - Progression. 04/17/15
    04/15 Genomic profiling reveals mutation into PTCL-NOS + AngioImmunoblastic T-Cell Lymphoma. Stage IV-B a second time. Two dozen tumors + small intestine (Ileum) involvement.
    04/22/15 TEC (Bendamustine, Etoposide, Carboplatin). Full response in two cycles. PET/CT both clear. Third cycle followed.
    06/15-07/15 Transplant preparation (X-rays, spinal taps, BMB, blood test, MUGA scan, lung function, CMV screening, C-Diff testing etc. etc. etc.) Intrathecal Methotrexate during spinal tap.
    BMB reveals 5) 26% blast cells of 20q Deletion Myelodysplastic Syndrome MDS), a bone marrow cancer and precursor to Acute Myeloid Leukemia.
    07/11-12/15 Cyclofosfamide + Fludarabine conditioning regimen.
    07/16/15 Total Body Irradiation.
    07/17/15 Moderate intensity Haploidentical Allogeneic Stem Cell Transplant receiving my son's peripheral blood stem cells.
    07/21-22/15 Triple dose Cyclofosfamide + Mesna, followed by immunosuppressants Tacrolimus and Mycophenolate Mofetil.
    07/23-08/03/15 Marrow producing zero blood cells. Fever. Hospitalized two weeks.
    08/04/15 Engraftment occurs, and blood cells are measurable - released from hospital.
    08/13/15 Day 26 - Marrow is 100% donor cells. Platelets climbing steadily, red cells follow.
    09/21/15 Acute skin Graft versus Host Disease arrives.
    DEXA scan reveals Osteoporosis.
    09/26/-11/03/15 Prednisone to control skin GvHD.
    11/2015 Acute GvHD re-classified to Chronic Graft versus Host Disease.
    05/2016 Tacrolimus stopped. Prednisone from 30-90mg daily tried. Sirolimus begun. Narrow-band UV-B therapy started, but discontinued for lack of response. One treatment of P-UVAreceived, but halted due to medication reaction.
    09/16/16 Three skin punch biopsies.
    11/04/16 GvHD clinical trial of Ofatumumab (Arzerra) + Prednisone + Methylprednisolone begun.
    12/16 Type II Diabetes, Hypertension - both treatment-related.
    05/17 Extracorporeal Photopheresis (ECP) begun in attempt to control chronic Graft-versus-Host-Disease (cGvHD. 8 year old Power Port removed and replaced with Vortex (Smart) Port for ECP.
    05/2017 Chronic anemia (low hematocrit). Chronic kidney disease. Cataracts from radiation and steroids.
    06/17 Trying various antibiotics in a search for tolerable prophylaxis.
    08/17 Bone marrow biopsy reveals the presence of 2% cells with 20q Deletion Myelodysplastic Syndrome, considered to be Minimum Residual Disease.
    12/17 Bone marrow biopsy reveals no abnormalities in the marrow - MDS eradicated. The steroid taper continues.
    01/18 Consented for Kadmon clinical trial.
    03/18 Began 400mg daily of KD025, a rho-Associated Coiled-coil Kinase 2 Inhibitor (ROCK2).
    09/18 Due to refractory GvHD, Extracorporeal Photopheresis halted after 15 months ue to lack of additional benefit.
    10/18 I was withdrawn from the Kadmon KD025 clinical trial due to increasing fatigue/lack of benefit.
    11/18 Began therapy with Ruxolitinib (Jakafi), a JAK 1&2 inhibitor class drug. Started at half-dose due to concerns with drug interactions.

    To date: 1 cancer, relapse, second relapse/mutation into 2 cancers, then 3 cancers simultaneously, 20 chemotherapy/GVHD drugs in 11 regimens (4 of them at least twice), 5 salvage regimens, 4 clinical trials, 5 post-transplant immuno-suppressant/modulatory drugs, the equivalent of 1,000 years of background radiation from 40+ CT series scans and about 24 PET scans.
    Both lymphoid and myeloid malignancies lend a certain symmetry to the hematological journey.

    Believing in the redemptive value of suffering makes all the difference.

  4. #4
    Newbie New User
    Join Date
    Sep 2018
    Posts
    3
    Quote Originally Posted by po18guy View Post
    Sorry to welcoe you here, but welcome you are! A friend's mother had a melanoma near the inside corner of her eye. It was removed with MOHS, but she had plastic surgery to restore the area, due to its location. It would be worth at least consulting with such a surgeon, so as to hear what is likely and weigh your options.
    Thank you! Great Forum. Doc says I will likely have more BCC's since I've had this one. I go for a "total skin check" in October and I do skin checks at home.

 

Similar Threads

  1. nervous about mohs to remove BCC on scalp
    By LisaCA in forum Melanoma and Skin Cancer Forum
    Replies: 5
    Last Post: 04-06-2015, 08:17 AM
  2. Mohs surgery and then plastics surgery?
    By Elizabeth1234 in forum Melanoma and Skin Cancer Forum
    Replies: 4
    Last Post: 06-17-2013, 06:40 PM
  3. Treated Acne and then developed Skin Cancer?
    By 2097 in forum Melanoma and Skin Cancer Forum
    Replies: 1
    Last Post: 03-19-2011, 01:39 AM
  4. BCC removal and skin graft - is it failing?
    By janhe in forum Melanoma and Skin Cancer Forum
    Replies: 1
    Last Post: 03-06-2007, 09:09 AM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •